Topic AllData science newsScience newsLife science newsNordic welfare newsHealth newsEducation newsLanguage & cultureSociety & economySustainability newsTeaching & studying at the UniversityHigher education & science policy Type AllNewsPress releaseIn briefEditorialArticleProfileEssayColumnCommentComment: Research MattersBooksFrom the Researcher’s PenCaseSpeech Listing <span class="icon--list-as-blocks"></span><span class="icon--list"></span> 31.10.2018 Health news Diabetes: Unconventional neurotrophic factor MANF may regenerate insulin-producing cells in the pancreas MANF has therapeutic potential for the treatment of Type 1 and Type 2 diabetes. 27.7.2018 Higher education & science policy ERC Starting Grants to four researchers at the University of Helsinki Four researchers from the University of Helsinki have received the European Research Council’s (ERC) Starting Grant. 18.4.2018 Health news The Chemical Industry Federation of Finland’s Innovation Award to the team of the Institute of Biotechnology and Herantis Pharma CDNF protein treatment for Parkinsons’ disease developed by Herantis Pharma and the team of the Institute of Biotechnology was presented with... 11.8.2017 Health news US department of defense grant to support ALS research at University of Helsinki With the help of the two-year Therapeutic Idea Award from the US Department of Defense professor Saarma and Dr. Voutilainen aim to generate more... 26.7.2017 Health news Additional funding for investigating the therapeutic role for neurotrophic factor MANF in type 1 diabetes Researchers have found that MANF protects and stimulates in the rodent model the proliferation of insulin-producing beta cells in the pancreas. 12.12.2016 Health news Significant Horizon 2020 funding for clinical study of the neurotrophic factor CDNF The European Union’s research and innovation programme Horizon 2020 has awarded a grant of approximately €6 million to the TreatER EU project...
31.10.2018 Health news Diabetes: Unconventional neurotrophic factor MANF may regenerate insulin-producing cells in the pancreas MANF has therapeutic potential for the treatment of Type 1 and Type 2 diabetes.
27.7.2018 Higher education & science policy ERC Starting Grants to four researchers at the University of Helsinki Four researchers from the University of Helsinki have received the European Research Council’s (ERC) Starting Grant.
18.4.2018 Health news The Chemical Industry Federation of Finland’s Innovation Award to the team of the Institute of Biotechnology and Herantis Pharma CDNF protein treatment for Parkinsons’ disease developed by Herantis Pharma and the team of the Institute of Biotechnology was presented with...
11.8.2017 Health news US department of defense grant to support ALS research at University of Helsinki With the help of the two-year Therapeutic Idea Award from the US Department of Defense professor Saarma and Dr. Voutilainen aim to generate more...
26.7.2017 Health news Additional funding for investigating the therapeutic role for neurotrophic factor MANF in type 1 diabetes Researchers have found that MANF protects and stimulates in the rodent model the proliferation of insulin-producing beta cells in the pancreas.
12.12.2016 Health news Significant Horizon 2020 funding for clinical study of the neurotrophic factor CDNF The European Union’s research and innovation programme Horizon 2020 has awarded a grant of approximately €6 million to the TreatER EU project...
